[D2-C2] ADA Round Table Discussion

3:25 PM - 4:55 PM JST(6:25 AM - 7:55 AM UTC)

[D2-C2-01] Advancing Drug Development: Comprehensive and Optimum Approaches to the Immunogenicity Assessment (Round Table Discussion)

* (Chairpersons) Hiroyuki Shimizu¹, *Hisanori Hara² (1. Mitsubishi Tanabe Pharma Corporation, 2. B2S Life Sciences)

Password required to view

Log in

or